Your browser doesn't support javascript.
loading
Illustrating potential effects of alternate control populations on real-world evidence-based statistical analyses.
Huang, Yidi; Yuan, William; Kohane, Isaac S; Beaulieu-Jones, Brett K.
Afiliação
  • Huang Y; Department of Biomedical Informatics, Harvard Medical School, Countway Library, Boston, Massachusetts, USA.
  • Yuan W; Department of Biomedical Informatics, Harvard Medical School, Countway Library, Boston, Massachusetts, USA.
  • Kohane IS; Department of Biomedical Informatics, Harvard Medical School, Countway Library, Boston, Massachusetts, USA.
  • Beaulieu-Jones BK; Department of Biomedical Informatics, Harvard Medical School, Countway Library, Boston, Massachusetts, USA.
JAMIA Open ; 4(2): ooab045, 2021 Apr.
Article em En | MEDLINE | ID: mdl-34142018
OBJECTIVE: Case-control study designs are commonly used in retrospective analyses of real-world evidence (RWE). Due to the increasingly wide availability of RWE, it can be difficult to determine whether findings are robust or the result of testing multiple hypotheses. MATERIALS AND METHODS: We investigate the potential effects of modifying cohort definitions in a case-control association study between depression and type 2 diabetes mellitus. We used a large (>75 million individuals) de-identified administrative claims database to observe the effects of minor changes to the requirements of glucose and hemoglobin A1c tests in the control group. RESULTS: We found that small permutations to the criteria used to define the control population result in significant shifts in both the demographic structure of the identified cohort as well as the odds ratio of association. These differences remain present when testing against age- and sex-matched controls. DISCUSSION: Analyses of RWE need to be carefully designed to avoid issues of multiple testing. Minor changes to control cohorts can lead to significantly different results and have the potential to alter even prospective studies through selection bias. CONCLUSION: We believe this work offers strong support for the need for robust guidelines, best practices, and regulations around the use of observational RWE for clinical or regulatory decision-making.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: JAMIA Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: JAMIA Open Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos